The Complex Interplay between Toxic Hallmark Proteins, Calmodulin-Binding Proteins, Ion Channels, and Receptors Involved in Calcium Dyshomeostasis in Neurodegeneration

Danton H. O'Day

DOI: https://doi.org/10.3390/biom14020173

IF: 6.064

2024-02-01

Biomolecules

Abstract:Calcium dyshomeostasis is an early critical event in neurodegeneration as exemplified by Alzheimer's (AD), Huntington's (HD) and Parkinson's (PD) diseases. Neuronal calcium homeostasis is maintained by a diversity of ion channels, buffers, calcium-binding protein effectors, and intracellular storage in the endoplasmic reticulum, mitochondria, and lysosomes. The function of these components and compartments is impacted by the toxic hallmark proteins of AD (amyloid beta and Tau), HD (huntingtin) and PD (alpha-synuclein) as well as by interactions with downstream calcium-binding proteins, especially calmodulin. Each of the toxic hallmark proteins (amyloid beta, Tau, huntingtin, and alpha-synuclein) binds to calmodulin. Multiple channels and receptors involved in calcium homeostasis and dysregulation also bind to and are regulated by calmodulin. The primary goal of this review is to show the complexity of these interactions and how they can impact research and the search for therapies. A secondary goal is to suggest that therapeutic targets downstream from calcium dyshomeostasis may offer greater opportunities for success.

biochemistry & molecular biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the complex interactions of calcium dyshomeostasis in neurodegenerative diseases (such as Alzheimer's disease (AD), Huntington's disease (HD) and Parkinson's disease (PD)) and its impact on disease progression. Specifically, the authors explored how the interactions among toxic marker proteins (such as amyloid - β protein and Tau protein in AD, mutant Huntington protein in HD, and α - synuclein in PD), calmodulin - binding proteins, ion channels and receptors affect calcium homeostasis, and further explored how these interactions affect the development of research and treatment strategies.

### Main Objectives:
1. **Demonstrate Complexity**: Reveal the complex interactions among toxic marker proteins, calmodulin - binding proteins, ion channels and receptors, and how these interactions affect calcium homeostasis.
2. **Propose Therapeutic Targets**: Suggest that looking for therapeutic targets downstream of calcium dyshomeostasis may offer a greater chance of success.

### Key Points:
- **Importance of Calcium Homeostasis**: Calcium signaling plays a crucial role in neuronal functions, including vesicle release, gene regulation, synaptic transmission, etc.
- **Calcium Dyshomeostasis**: Calcium dyshomeostasis is a key event in the early stage of neurodegenerative diseases, leading to abnormal intracellular calcium levels.
- **Role of Toxic Marker Proteins**: Amyloid - β protein, phosphorylated Tau protein, mutant Huntington protein and α - synuclein further exacerbate calcium dyshomeostasis by affecting the functions of receptors and ion channels.
- **Role of Calmodulin (CaM)**: Calmodulin is an important calcium - binding protein involved in regulating the functions of multiple receptors and ion channels. The binding of toxic marker proteins to CaM further affects calcium homeostasis.
- **Calcium - Binding Proteins (CaBPs)**: Calcium - binding proteins such as calmodulin and calpain play important roles in calcium dyshomeostasis, and their abnormal activities may lead to neurotoxicity.

### Specific Mechanisms:
- **Receptors and Ion Channels**: Multiple receptors and ion channels (such as mGluR, NMDAR, PMCA, VGCC, etc.) bind to calmodulin and are affected by toxic marker proteins.
- **Calmodulin Hypothesis**: Calcium dyshomeostasis leads to over - activation of calmodulin, which in turn drives the abnormal activities of calcium - dependent calmodulin - binding proteins, triggering pathological processes such as autophagy, neurotoxicity and neuroinflammation.

Through these studies, the authors aim to provide a new perspective for understanding the pathogenesis of neurodegenerative diseases and a theoretical basis for developing new treatment strategies.